REM Sleep Parasomnias clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
North American Prodromal Synucleinopathy Consortium Stage 2
Sorry, not currently recruiting here
This study will enroll participants with idiopathic REM sleep behavior disorder (RBD) and healthy controls for the purpose of preparing for a clinical trial of neuroprotective treatments against synucleinopathies.
Los Angeles, California and other locations
Our lead scientists for REM Sleep Parasomnias research studies include Alon Avidan, MD, MPH.
Last updated: